Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method.

Elizondo-Montemayor L, Alvarez MM, Hernández-Torre M, Ugalde-Casas PA, Lam-Franco L, Bustamante-Careaga H, Castilleja-Leal F, Contreras-Castillo J, Moreno-Sánchez H, Tamargo-Barrera D, López-Pacheco F, Freiden PJ, Schultz-Cherry S.

Int J Infect Dis. 2011 Nov;15(11):e781-6. doi: 10.1016/j.ijid.2011.07.002. Epub 2011 Aug 19.

2.

Clinical and epidemiological features of 2009 pandemic H1N1 influenza differ slightly according to seroprevalence status during the second wave in the general population in México.

Elizondo-Montemayor L, Hernández-Torre M, Ugalde-Casas PA, Santos-Guzmán J, Serrano-González M, Gutiérrez NG, Lam-Franco L, Tamargo-Barrera D, Martínez U, Bustamante-Careaga H, Alvarez MM, Schultz-Cherry S.

Respir Care. 2012 Oct;57(10):1586-93. Epub 2012 Mar 12.

3.

H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.

Kumar S, Fan J, Melzer-Lange M, Trost J, Havens PL, Willoughby RE, Chusid MJ, Henrickson KJ.

Pediatr Emerg Care. 2011 Sep;27(9):804-7. doi: 10.1097/PEC.0b013e31822c125e.

PMID:
21878831
4.

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, Zambon M, Miller E.

Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.

5.

Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan.

Chan YJ, Lee CL, Hwang SJ, Fung CP, Wang FD, Yen DH, Tsai CH, Chen YM, Lee SD.

J Chin Med Assoc. 2010 Feb;73(2):62-6. doi: 10.1016/S1726-4901(10)70003-4.

6.

Seroprevalence of Pandemic A(H1N1) pmd09 Virus Antibodies in Mexican Health Care Workers Before and After Vaccination.

Aguilar-Madrid G, Castelán-Vega JA, Juárez-Pérez CA, Ribas-Aparicio RM, Estrada-García I, Baltierra-Jasso L, Cervantes-Servín N, Méndez-Ortega V, Haro-García LC, Sánchez-Román FR, Ortiz-Navarrete V, Fabila-Castillo LH, Magaña-Hernández A, Chávez-Negrete A, Salamanca-Gómez FA, Jiménez-Alberto A.

Arch Med Res. 2015 Feb;46(2):154-63. doi: 10.1016/j.arcmed.2015.03.001. Epub 2015 Mar 18.

PMID:
25796508
7.

Seroprevalence study of antibodies against influenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia.

Subelj V, Prosenc K, Sočan M.

Wien Klin Wochenschr. 2012 Mar;124(5-6):177-80. doi: 10.1007/s00508-012-0126-0. Epub 2012 Feb 15.

PMID:
22327938
8.

Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.

Maltezou HC, Katerelos P, Mavrouli M, Lourida A, Routsias JG, Spanakis N, Maragos A, Tedoma A, Bassiakos Y, Koratzanis G, Mantagos S, Metallidis S, Katragkou A, Nikolaidis P, Roilides E, Theodoridou M, Tsakris A.

Vaccine. 2011 Sep 2;29(38):6664-9. doi: 10.1016/j.vaccine.2011.06.098. Epub 2011 Jul 14.

PMID:
21762749
9.

Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.

Tandale BV, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, Shelke VN, Mishra AC.

BMC Infect Dis. 2010 Aug 25;10:255. doi: 10.1186/1471-2334-10-255.

10.

Pandemic 2009 influenza A (H1N1) virus among Japanese healthcare workers: seroprevalence and risk factors.

Nukui Y, Hatakeyama S, Kitazawa T, Mahira T, Shintani Y, Moriya K.

Infect Control Hosp Epidemiol. 2012 Jan;33(1):58-62. doi: 10.1086/663208. Epub 2011 Nov 22.

PMID:
22173523
11.

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M.

Lancet. 2010 Mar 27;375(9720):1100-8. doi: 10.1016/S0140-6736(09)62126-7. Epub 2010 Jan 21.

PMID:
20096450
12.

Serological survey of 2009 H1N1 influenza in residents of Beijing, China.

Deng Y, Pang XH, Yang P, Shi WX, Tian LL, Liu BW, Li S, Cui SJ, Li Y, Lu GL, Zhang L, Zhang X, Liu B, Seale H, Huang F, Wang QY.

Epidemiol Infect. 2011 Jan;139(1):52-8. doi: 10.1017/S0950268810002189. Epub 2010 Sep 21.

PMID:
20854713
13.

Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.

Labato MI, Contrini MM, Lazzarini D, Campos AM, Gauna ML, Claros R, López EL, Savy VL, Luna CM.

Int J Infect Dis. 2014 Feb;19:20-5. doi: 10.1016/j.ijid.2013.09.021. Epub 2013 Nov 6.

14.

Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?

Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW.

Med Microbiol Immunol. 2010 May;199(2):117-21. doi: 10.1007/s00430-010-0143-4. Epub 2010 Feb 17.

PMID:
20162304
15.

Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011.

Hoschler K, Thompson C, Andrews N, Galiano M, Pebody R, Ellis J, Stanford E, Baguelin M, Miller E, Zambon M.

Emerg Infect Dis. 2012 Nov;18(11):1894-7. doi: 10.3201/eid1811.120720.

16.

The seroprevalence of pandemic influenza H1N1 (2009) virus in China.

Xu C, Bai T, Iuliano AD, Wang M, Yang L, Wen L, Zeng Y, Li X, Chen T, Wang W, Hu Y, Yang L, Li Z, Zou S, Li D, Wang S, Feng Z, Zhang Y, Yu H, Yang W, Wang Y, Widdowson MA, Shu Y.

PLoS One. 2011 Apr 21;6(4):e17919. doi: 10.1371/journal.pone.0017919.

17.

Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.

Gözalan A, Altaş AB, Sevencan F, Akın L, Korukluoğlu G, Kara S, Sevindi DF, Ertek M; Study Group.

Jpn J Infect Dis. 2012;65(1):13-8.

18.

Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.

Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, Seston M, Lina B, Nougairede A, Charrel R, Flahault A, de Lamballerie X.

Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2.

19.

Post-pandemic seroprevalence of 2009 pandemic influenza A (H1N1) virus in Shandong Province, China.

Liu T, Li Z, Song S, Zhang S, Wang Y, Lin Y, Wang S, Wang X, Xu A, Bi Z.

Jpn J Infect Dis. 2012;65(5):410-4.

20.

Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan.

Iwatsuki-Horimoto K, Horimoto T, Tamura D, Kiso M, Kawakami E, Hatakeyama S, Ebihara Y, Koibuchi T, Fujii T, Takahashi K, Shimojima M, Sakai-Tagawa Y, Ito M, Sakabe S, Iwasa A, Takahashi K, Ishii T, Gorai T, Tsuji K, Iwamoto A, Kawaoka Y.

Clin Vaccine Immunol. 2011 May;18(5):860-6. doi: 10.1128/CVI.00428-10. Epub 2011 Feb 23.

Items per page

Supplemental Content

Write to the Help Desk